Publikationen (46) Publikationen von LUIS GARCÍA GARCÍA

2024

  1. Astrocytic Ca2+ activation by chemogenetics mitigates the effect of kainic acid-induced excitotoxicity on the hippocampus

    GLIA

  2. Effects of chronic treatment with metformin on brain glucose hypometabolism and central insulin actions in transgenic mice with tauopathy

    Heliyon, Vol. 10, Núm. 15

2023

  1. A Single High Dose of Flufenamic Acid in Rats does not Reduce the Damage Associated with the Rat Lithium-Pilocarpine Model of Status Epilepticus but Leads to Deleterious Outcomes

    Journal of integrative neuroscience, Vol. 22, Núm. 3, pp. 75

  2. The vasodilator naftidrofuryl attenuates short-term brain glucose hypometabolism in the lithium-pilocarpine rat model of status epilepticus without providing neuroprotection

    European Journal of Pharmacology, Vol. 939

  3. Tolerancia y procesos de adaptación

    Fundamentos de farmacología básica y clínica (Editorial Médica Panamericana), pp. 355-366

2022

  1. Experimental models in the study of epileptogenesis

    ANALES RANM, Vol. 139, Núm. 139(02), pp. 140-149

  2. Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain

    Pharmaceutics, Vol. 14, Núm. 11

  3. Micro-and Nano-Systems Developed for Tolcapone in Parkinson’s Disease

    Pharmaceutics, Vol. 14, Núm. 5

  4. PET Imaging and Neurohistochemistry Reveal that Curcumin Attenuates Brain Hypometabolism and Hippocampal Damage Induced by Status Epilepticus in Rats

    Planta Medica, Vol. 89, Núm. 4, pp. 364-376

  5. Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases

    Frontiers in Endocrinology, Vol. 13

2021

  1. 99mTc-HMPAO SPECT imaging reveals brain hypoperfusion during status epilepticus

    Metabolic Brain Disease, Vol. 36, Núm. 8, pp. 2597-2602

2019

  1. Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood-Brain Barrier Both in Vitro and in Vivo

    Molecular Pharmaceutics, Vol. 16, Núm. 5, pp. 1999-2010

  2. PET Neuroimaging Reveals Serotonergic and Metabolic Dysfunctions in the Hippocampal Electrical Kindling Model of Epileptogenesis

    Neuroscience, Vol. 409, pp. 101-110

2018

  1. Metyrapone prevents acute glucose hypermetabolism and short-term brain damage induced by intrahippocampal administration of 4-aminopyridine in rats

    Neurochemistry International, Vol. 113, pp. 92-106

2017

  1. Anxiogenic-like effects of fluoxetine render adult male rats vulnerable to the effects of a novel stress

    Pharmacology Biochemistry and Behavior, Vol. 153, pp. 32-44

  2. Efficacy of ropinirole-loaded PLGA microspheres for the reversion of rotenone- induced parkinsonism

    Current Pharmaceutical Design, Vol. 23, Núm. 23, pp. 3423-3431

  3. Insulin regulates astrocytic glucose handling through cooperation with IGF-I

    Diabetes, Vol. 66, Núm. 1, pp. 64-74

  4. Metyrapone prevents brain damage induced by status epilepticus in the rat lithium-pilocarpine model

    Neuropharmacology, Vol. 123, pp. 261-273

  5. Nanotechnology-based drug delivery of ropinirole for parkinson’s disease

    Drug Delivery, Vol. 24, Núm. 1, pp. 1112-1123

  6. Subacute fluoxetine reduces signs of hippocampal damage induced by a single convulsant dose of 4-aminopyridine in rats

    CNS and Neurological Disorders - Drug Targets, Vol. 16, Núm. 6, pp. 694-704